Buy YK 11
60 Capsules | 5mg per Capsule | US SARMs
What Is YK11?
YK11, sometimes referred to as YK-11 SARM, is a synthetic androgen receptor modulator designed to interact selectively with androgen receptors. It was first developed to study the pathways involved in muscle and bone development.
In laboratory settings, YK-11 acts as a gene-specific agonist of the androgen receptor (AR) and influences multiple anabolic pathways. Studies on cell lines such as MDA-MB-453 and C2C12 myoblasts have shown that YK-11 can stimulate myogenic factors like MyoD and Myf5—key regulators of muscle cell differentiation.
Unlike injectable androgens, YK-11 is orally bioavailable, which allows researchers to evaluate its effects through oral administration in controlled environments.
YK 11 Benefits from Clinical Research
1. Muscle Growth and Follistatin Expression
One of YK-11’s defining features is its connection to follistatin, a naturally occurring protein that regulates muscle growth by inhibiting myostatin and related catabolic proteins (Activin A, Activin B).
Research suggests that YK-11 may stimulate follistatin expression both locally and systemically, which in turn can:
- Promote muscle cell differentiation
- Support amino acid and glucose uptake in skeletal muscle
- Reduce myostatin-related muscle breakdown
This mechanism distinguishes YK-11 from traditional anabolic agents and provides a promising avenue for continued study into muscle preservation and recovery.
2. Bone Cell Research and Growth Potential
In vitro testing on MC3T3-E1 osteoblast cells showed that YK-11, alone or in combination with DHT, can accelerate cell proliferation and mineralization. The treatment also increased the expression of bone differentiation markers such as osteocalcin and osteoprotegerin.
These effects appear to be mediated through the androgen receptor (AR) and Akt phosphorylation pathway, which are important in bone tissue regulation and recovery.
3. Muscle Wasting and Cytokine Response
Animal studies examining sepsis-induced muscle loss have reported that YK-11 treatment correlated with:
- Improved muscle tissue protection
- Reduced cytokine-related inflammation
- Lower mortality rates in experimental models
These outcomes were attributed to myostatin suppression and increased follistatin gene expression, making YK-11 a continuing focus in the field of muscle-wasting research.
Potential YK11 Side Effects
Published data on YK-11 side effects remains limited. However, anecdotal reports and structural similarities to other androgenic compounds suggest the need for caution in laboratory environments. Possible observations include:
- Temporary joint discomfort
- Skin and hair changes
- Fluctuations in lipid and hormone markers
Because YK-11 acts on the androgen receptor, similar considerations apply as with other AR-modulating compounds. Researchers should handle this material under appropriate conditions and within approved safety protocols.